Vertex Pharmaceuticals(DE:VX1)
€487.20-1.80 (-0.37%)
DE:VX1
Vertex Pharmaceuticals Revenue
€487.20
At close:-1.80 (-0.37%)
Vertex Pharmaceuticals (VX1) Revenue
23 Followers
Vertex Pharmaceuticals Revenue
Vertex Pharmaceuticals had a revenue of 3.44B in the quarter ending Sep 30, 2026, with 3.21%. This bring the company's revenue in the last twelve months to 12.99B, Increased 2.89%. In the fiscal year ending Dec 31, 2025, Vertex Pharmaceuticals had annual revenue of 12.07B with 9.57% growth.
- Revenue (ttm)
- 12.99B
- Revenue Growth
- 5.62%
- P/S Ratio
- 10.37
- Revenue/Employee
- EUR 1,886,656
- Employees
- 6,400
- Market Cap
- EUR 125.18B
Revenue Chart
Vertex Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.07B | 1.05B | 9.57% |
| Dec 31, 2024 | 11.02B | 1.15B | 11.66% |
| Dec 31, 2023 | 9.87B | 938.50M | 10.51% |
| Dec 31, 2022 | 8.93B | 1.36B | 17.91% |
| Dec 31, 2021 | 7.57B | 1.37B | 22.06% |
| Dec 31, 2020 | 6.21B | 2.04B | 49.07% |
| Dec 31, 2019 | 4.16B | 1.12B | 36.59% |
| Dec 31, 2018 | 3.05B | 558.95M | 22.46% |
| Dec 31, 2017 | 2.49B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.